Haleon to invest $54 mln in US R&D centre to ... invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Haleon PLC HLN advanced 1.83% to £4.02 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.57% to 8,633.75.

Uncertain demand environment in the U.S. - CFO Reaffirms 2025 targets Q1 organic revenue rises April 30 (Reuters) - British consumer healthcare group Haleon (HLN.L), opens new tab on Wednesday ...

(RTTNews) - Haleon Plc (HLN), a British consumer healthcare company, reported Wednesday weak revenues in its first quarter on a reported basis, while organic revenue grew 3.5 percent with growth ...

The UK pharma group – now a therapeutics and vaccines pure-play since the spin-off of Haleon in July – also raised its financial forecasts for the full year for the second time in consecutive ...

30 April 2025: Haleon plc (the "Company" or "Haleon") today announces its Q1 trading statement for the year ending 31 December 2025 is available at: http://www.rns ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

SS Paul, site head and vice president of manufacturing at Haleon. Picture: Maura Hickey Employing around 760 people at its Dungarvan base, Haleon, formerly GSK, has had a long and deep-rooted ...

Shares of Haleon PLC HLN advanced 2.50% to £3.98 Friday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 1.17% to 8,596.35.